ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 55 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,050,000 | -43.6% | 55,652 | -64.8% | 0.00% | -50.0% |
| Q2 2019 | $1,862,000 | +214.0% | 158,268 | +264.5% | 0.00% | +100.0% |
| Q1 2019 | $593,000 | +11.7% | 43,417 | -16.2% | 0.00% | 0.0% |
| Q4 2018 | $531,000 | -90.1% | 51,807 | -84.0% | 0.00% | -80.0% |
| Q3 2018 | $5,377,000 | +144.6% | 322,970 | +132.2% | 0.01% | +150.0% |
| Q2 2018 | $2,198,000 | -17.7% | 139,115 | -33.9% | 0.00% | 0.0% |
| Q1 2018 | $2,672,000 | +315.6% | 210,377 | +274.3% | 0.00% | +100.0% |
| Q4 2017 | $643,000 | -41.4% | 56,208 | -37.2% | 0.00% | 0.0% |
| Q3 2017 | $1,097,000 | -27.7% | 89,511 | -32.5% | 0.00% | 0.0% |
| Q2 2017 | $1,518,000 | -70.1% | 132,524 | -45.6% | 0.00% | -80.0% |
| Q1 2017 | $5,071,000 | +19.8% | 243,807 | +19.8% | 0.01% | +25.0% |
| Q4 2016 | $4,234,000 | -36.3% | 203,547 | +0.3% | 0.00% | -33.3% |
| Q3 2016 | $6,648,000 | +42.4% | 202,839 | +8.5% | 0.01% | +20.0% |
| Q2 2016 | $4,667,000 | +2.1% | 186,912 | +0.1% | 0.01% | -16.7% |
| Q1 2016 | $4,571,000 | +21.3% | 186,633 | +63.7% | 0.01% | +50.0% |
| Q4 2015 | $3,767,000 | +22.7% | 113,997 | +21.7% | 0.00% | 0.0% |
| Q3 2015 | $3,069,000 | +1.2% | 93,665 | +63.6% | 0.00% | +33.3% |
| Q2 2015 | $3,032,000 | +188.2% | 57,254 | +57.0% | 0.00% | +200.0% |
| Q1 2015 | $1,052,000 | +139.6% | 36,460 | +142.0% | 0.00% | – |
| Q4 2014 | $439,000 | +99.5% | 15,064 | -13.2% | 0.00% | – |
| Q3 2014 | $220,000 | – | 17,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |